159 related articles for article (PubMed ID: 9400592)
1. Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death.
Geiger KD; Nash TC; Sawyer S; Krahl T; Patstone G; Reed JC; Krajewski S; Dalton D; Buchmeier MJ; Sarvetnick N
Virology; 1997 Nov; 238(2):189-97. PubMed ID: 9400592
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
3. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
Noisakran S; Campbell IL; Carr DJ
J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
[TBL] [Abstract][Full Text] [Related]
5. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
[TBL] [Abstract][Full Text] [Related]
6. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
[TBL] [Abstract][Full Text] [Related]
8. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection.
Reading PC; Whitney PG; Barr DP; Smyth MJ; Brooks AG
Eur J Immunol; 2006 Apr; 36(4):897-905. PubMed ID: 16552715
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
11. Differences in inhibition of apoptosis depending on the virulence of used herpes simplex virus type 1 strains. Function of interferon alpha in apoptotic death of virus infected cells.
Rechnio M; Litwińska B
Acta Microbiol Pol; 2003; 52(3):271-6. PubMed ID: 14743979
[TBL] [Abstract][Full Text] [Related]
12. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
13. Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes.
Liu T; Chambers TJ
J Virol; 2001 Mar; 75(5):2107-18. PubMed ID: 11160715
[TBL] [Abstract][Full Text] [Related]
14. Herpesvirus infection of ICAM-1-deficient mice.
Jung HW; Jung CR; Choi BK; Vinay DS; Hill JM; Gebhardt BM; Kwon BS
Curr Eye Res; 2004; 29(2-3):201-8. PubMed ID: 15512968
[TBL] [Abstract][Full Text] [Related]
15. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection.
Yamaji M; Shudo J
Int Immunopharmacol; 2009 Jul; 9(7-8):984-9. PubMed ID: 19362169
[TBL] [Abstract][Full Text] [Related]
17. [A kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccination].
Arefian E; Bamdad T; Soleimanjahi H; Akhood MR; Parsania M; Ghaemi A
Mol Biol (Mosk); 2009; 43(3):422-8. PubMed ID: 19548528
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice expressing the thymus leukemia antigen fail to control cutaneous herpes simplex virus infection.
Sharma P; Johnson CA; Bonneau RH; Lang CM; Chorney MJ
Cell Immunol; 1996 Nov; 174(1):84-9. PubMed ID: 8929457
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.
Geiger K; Howes EL; Sarvetnick N
J Virol; 1994 Sep; 68(9):5556-67. PubMed ID: 8057437
[TBL] [Abstract][Full Text] [Related]
20. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
